Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

SHE:002422 Revenue

Sichuan Kelun Pharmaceutical had revenue of 4.27B CNY in the quarter ending September 30, 2026, with 1.93% growth. This brings the company's total for the last twelve months to 18.35B, up 0.27% year-over-year. In the year 2025, Sichuan Kelun Pharmaceutical had annual revenue of 18.51B, down -15.13%. That makes Sichuan Kelun Pharmaceutical the 4,041st largest company in the world by revenue and 519th in China.

• Revenue (ttm): 18.35B
• Revenue Growth: +0.27%
• P/S Ratio: 3.45
• Revenue / Employee: 911.66K
• Employees: 20,127
• Market Cap: 65.68B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Other Business Segments 12.15B 64.5%
• Twinings Branch 4.62B 24.5%
• Botai Branch 2.06B 10.9%

By Geography

Chart

• Eastern China 5.08B 27.5%
• Southwest China 3.78B 20.4%
• International Business 2.49B 13.4%
• Central China 2.24B 12.1%
• Northern China 1.72B 9.3%
• South China 1.47B 7.9%
• North-West China 1.10B 5.9%
• North-East Region 630.79M 3.4%

Fiscal year ended Dec 31, 2025 See the full SHE:002422 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	18.51B	-3.30B	-15.13%
Dec 31, 2024	21.81B	358.49M	1.67%
Dec 31, 2023	21.45B	2.42B	12.69%
Jan 1, 2023	19.04B	1.76B	10.19%
Jan 1, 2022	17.28B	813.21M	4.94%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error